• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Multi-channel multi-task deep learning for predicting and mutations of non-small cell lung cancer on CT images.用于基于CT图像预测非小细胞肺癌及突变的多通道多任务深度学习
Quant Imaging Med Surg. 2021 Jun;11(6):2354-2375. doi: 10.21037/qims-20-600.
2
Deep learning for predicting epidermal growth factor receptor mutations of non-small cell lung cancer on PET/CT images.基于PET/CT图像的深度学习预测非小细胞肺癌表皮生长因子受体突变
Quant Imaging Med Surg. 2023 Mar 1;13(3):1286-1299. doi: 10.21037/qims-22-760. Epub 2023 Feb 6.
3
Machine Learning-Based Radiomics Signatures for EGFR and KRAS Mutations Prediction in Non-Small-Cell Lung Cancer.基于机器学习的放射组学特征预测非小细胞肺癌中 EGFR 和 KRAS 突变。
Int J Mol Sci. 2021 Aug 26;22(17):9254. doi: 10.3390/ijms22179254.
4
Impact of feature harmonization on radiogenomics analysis: Prediction of EGFR and KRAS mutations from non-small cell lung cancer PET/CT images.特征归一化对放射基因组学分析的影响:从非小细胞肺癌PET/CT图像预测EGFR和KRAS突变
Comput Biol Med. 2022 Mar;142:105230. doi: 10.1016/j.compbiomed.2022.105230. Epub 2022 Jan 11.
5
Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.使用多模态成像和机器学习算法的下一代放射基因组学测序预测非小细胞肺癌患者的EGFR和KRAS突变状态
Mol Imaging Biol. 2020 Aug;22(4):1132-1148. doi: 10.1007/s11307-020-01487-8.
6
CT-based non-invasive identification of the most common gene mutation status in patients with non-small cell lung cancer.基于CT的非小细胞肺癌患者最常见基因突变状态的无创识别
Med Phys. 2024 Mar;51(3):1872-1882. doi: 10.1002/mp.16744. Epub 2023 Sep 14.
7
Radiogenomic System for Non-Invasive Identification of Multiple Actionable Mutations and PD-L1 Expression in Non-Small Cell Lung Cancer Based on CT Images.基于CT图像的非小细胞肺癌中多种可操作突变和PD-L1表达的无创识别放射基因组系统
Cancers (Basel). 2022 Oct 2;14(19):4823. doi: 10.3390/cancers14194823.
8
Hybrid deep multi-task learning radiomics approach for predicting EGFR mutation status of non-small cell lung cancer in CT images.用于预测CT图像中非小细胞肺癌EGFR突变状态的混合深度多任务学习放射组学方法
Phys Med Biol. 2023 Dec 12;68(24). doi: 10.1088/1361-6560/ad0d43.
9
Dual-energy spectral CT characteristics in surgically resected lung adenocarcinoma: comparison between Kirsten rat sarcoma viral oncogene mutations and epidermal growth factor receptor mutations.手术切除肺腺癌的双能光谱 CT 特征:Kirsten 大鼠肉瘤病毒癌基因突变与表皮生长因子受体突变的比较。
Cancer Imaging. 2019 Nov 29;19(1):77. doi: 10.1186/s40644-019-0261-1.
10
Simultaneous Identification of and Mutations in Patients with Non-Small Cell Lung Cancer by Machine Learning-Derived Three-Dimensional Radiomics.通过机器学习衍生的三维放射组学同时鉴定非小细胞肺癌患者中的 和 突变
Cancers (Basel). 2021 Apr 10;13(8):1814. doi: 10.3390/cancers13081814.

引用本文的文献

1
Prediction of oncogene mutation status in non-small cell lung cancer: a systematic review and meta-analysis with a special focus on artificial intelligence-based methods.非小细胞肺癌中癌基因突变状态的预测:一项系统综述和荟萃分析,特别关注基于人工智能的方法
Eur Radiol. 2025 Sep 8. doi: 10.1007/s00330-025-11962-x.
2
CXR-MultiTaskNet a unified deep learning framework for joint disease localization and classification in chest radiographs.CXR-MultiTaskNet:一种用于胸部X光片中疾病联合定位与分类的统一深度学习框架。
Sci Rep. 2025 Aug 31;15(1):32022. doi: 10.1038/s41598-025-16669-z.
3
Machine learning approaches for EGFR mutation status prediction in NSCLC: an updated systematic review.用于非小细胞肺癌中表皮生长因子受体突变状态预测的机器学习方法:一项更新的系统评价
Front Oncol. 2025 Jul 10;15:1576461. doi: 10.3389/fonc.2025.1576461. eCollection 2025.
4
Construction of a radiogenomics predictive model for KRAS mutation status in patients with non-small cell lung cancer.非小细胞肺癌患者KRAS突变状态的放射基因组学预测模型构建
J Thorac Dis. 2025 Jun 30;17(6):3749-3761. doi: 10.21037/jtd-2024-2003. Epub 2025 Jun 26.
5
AI models for the identification of prognostic and predictive biomarkers in lung cancer: a systematic review and meta-analysis.用于识别肺癌预后和预测生物标志物的人工智能模型:系统评价与荟萃分析
Front Oncol. 2025 Feb 26;15:1424647. doi: 10.3389/fonc.2025.1424647. eCollection 2025.
6
Machine Learning-Based Radiomics Analysis for Identifying KRAS Mutations in Non-Small-Cell Lung Cancer from CT Images: Challenges, Insights and Implications.基于机器学习的影像组学分析用于从CT图像识别非小细胞肺癌中的KRAS突变:挑战、见解与启示
Life (Basel). 2025 Jan 11;15(1):83. doi: 10.3390/life15010083.
7
Predicting epidermal growth factor receptor mutation status of lung adenocarcinoma based on PET/CT images using deep learning.基于深度学习利用PET/CT图像预测肺腺癌表皮生长因子受体突变状态
Front Oncol. 2024 Dec 13;14:1458374. doi: 10.3389/fonc.2024.1458374. eCollection 2024.
8
The future of multimodal artificial intelligence models for integrating imaging and clinical metadata: a narrative review.整合影像学与临床元数据的多模态人工智能模型的未来:一篇综述
Diagn Interv Radiol. 2024 Oct 1. doi: 10.4274/dir.2024.242631.
9
Predicting Gene Comutation of EGFR and TP53 by Radiomics and Deep Learning in Patients With Lung Adenocarcinomas.通过放射组学和深度学习预测肺腺癌患者的EGFR和TP53基因变异
J Thorac Imaging. 2025 May 1;40(3):e0817. doi: 10.1097/RTI.0000000000000817.
10
Deep learning in pulmonary nodule detection and segmentation: a systematic review.深度学习在肺结节检测与分割中的应用:一项系统综述。
Eur Radiol. 2025 Jan;35(1):255-266. doi: 10.1007/s00330-024-10907-0. Epub 2024 Jul 10.

本文引用的文献

1
Automatic detection of pulmonary nodules on CT images with YOLOv3: development and evaluation using simulated and patient data.使用YOLOv3在CT图像上自动检测肺结节:基于模拟数据和患者数据的开发与评估
Quant Imaging Med Surg. 2020 Oct;10(10):1917-1929. doi: 10.21037/qims-19-883.
2
Implementation strategy of a CNN model affects the performance of CT assessment of EGFR mutation status in lung cancer patients.卷积神经网络(CNN)模型的实施策略会影响肺癌患者表皮生长因子受体(EGFR)突变状态的CT评估性能。
IEEE Access. 2019;7:64583-64591. doi: 10.1109/access.2019.2916557. Epub 2019 May 13.
3
Combination of generative adversarial network and convolutional neural network for automatic subcentimeter pulmonary adenocarcinoma classification.生成对抗网络与卷积神经网络相结合用于亚厘米级肺腺癌的自动分类
Quant Imaging Med Surg. 2020 Jun;10(6):1249-1264. doi: 10.21037/qims-19-982.
4
Radiomics for the prediction of EGFR mutation subtypes in non-small cell lung cancer.基于影像组学的非小细胞肺癌表皮生长因子受体突变亚型预测。
Med Phys. 2019 Oct;46(10):4545-4552. doi: 10.1002/mp.13747. Epub 2019 Aug 20.
5
Detection of epithelial growth factor receptor () mutations on CT images of patients with lung adenocarcinoma using radiomics and/or multi-level residual convolutionary neural networks.利用影像组学和/或多级残差卷积神经网络在肺腺癌患者的CT图像上检测表皮生长因子受体()突变
J Thorac Dis. 2018 Dec;10(12):6624-6635. doi: 10.21037/jtd.2018.11.03.
6
Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning.利用深度学习技术在 CT 图像上预测肺腺癌中的 EGFR 突变状态。
Eur Respir J. 2019 Mar 28;53(3). doi: 10.1183/13993003.00986-2018. Print 2019 Mar.
7
Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?非小细胞肺癌的CT影像组学分析能否预测组织学类型和表皮生长因子受体(EGFR)突变状态?
Medicine (Baltimore). 2019 Jan;98(1):e13963. doi: 10.1097/MD.0000000000013963.
8
Genomics of non-small cell lung cancer (NSCLC): Association between CT-based imaging features and EGFR and K-RAS mutations in 122 patients-An external validation.非小细胞肺癌(NSCLC)的基因组学:122 例患者 CT 影像特征与 EGFR 和 K-RAS 突变的相关性——一项外部验证。
Eur J Radiol. 2019 Jan;110:148-155. doi: 10.1016/j.ejrad.2018.11.032. Epub 2018 Nov 28.
9
and Amplifications Mediate Resistance to Rociletinib and Osimertinib in Acquired Afatinib-Resistant NSCLC Harboring Exon 19 Deletion/T790M in .并扩增介导获得性阿法替尼耐药 NSCLC 中 Exon19 缺失/T790M 对 Rociletinib 和奥希替尼的耐药性。
Mol Cancer Ther. 2019 Jan;18(1):112-126. doi: 10.1158/1535-7163.MCT-18-0591. Epub 2018 Oct 15.
10
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.度伐利尤单抗化疗和放疗后用于 III 期非小细胞肺癌的总生存。
N Engl J Med. 2018 Dec 13;379(24):2342-2350. doi: 10.1056/NEJMoa1809697. Epub 2018 Sep 25.

用于基于CT图像预测非小细胞肺癌及突变的多通道多任务深度学习

Multi-channel multi-task deep learning for predicting and mutations of non-small cell lung cancer on CT images.

作者信息

Dong Yunyun, Hou Lina, Yang Wenkai, Han Jiahao, Wang Jiawen, Qiang Yan, Zhao Juanjuan, Hou Jiaxin, Song Kai, Ma Yulan, Kazihise Ntikurako Guy Fernand, Cui Yanfen, Yang Xiaotang

机构信息

School of Software, Taiyuan University of Technology, Taiyuan, China.

School of Information and Computer, Taiyuan University of Technology, Taiyuan, China.

出版信息

Quant Imaging Med Surg. 2021 Jun;11(6):2354-2375. doi: 10.21037/qims-20-600.

DOI:10.21037/qims-20-600
PMID:34079707
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8107307/
Abstract

BACKGROUND

Predicting the mutation statuses of 2 essential pathogenic genes [epidermal growth factor receptor () and Kirsten rat sarcoma ()] in non-small cell lung cancer (NSCLC) based on CT is valuable for targeted therapy because it is a non-invasive and less costly method. Although deep learning technology has realized substantial computer vision achievements, CT imaging being used to predict gene mutations remains challenging due to small dataset limitations.

METHODS

We propose a multi-channel and multi-task deep learning (MMDL) model for the simultaneous prediction of and mutation statuses based on CT images. First, we decomposed each 3D lung nodule into 9 views. Then, we used the pre-trained inception-attention-resnet model for each view to learn the features of the nodules. By combining 9 inception-attention-resnet models to predict the types of gene mutations in lung nodules, the models were adaptively weighted, and the proposed MMDL model could be trained end-to-end. The MMDL model utilized multiple channels to characterize the nodule more comprehensively and integrate patient personal information into our learning process.

RESULTS

We trained the proposed MMDL model using a dataset of 363 patients collected by our partner hospital and conducted a multi-center validation on 162 patients in The Cancer Imaging Archive (TCIA) public dataset. The accuracies for the prediction of and mutations were, respectively, 79.43% and 72.25% in the training dataset and 75.06% and 69.64% in the validation dataset.

CONCLUSIONS

The experimental results demonstrated that the proposed MMDL model outperformed the latest methods in predicting and mutations in NSCLC.

摘要

背景

基于CT预测非小细胞肺癌(NSCLC)中两个关键致病基因[表皮生长因子受体(EGFR)和 Kirsten 大鼠肉瘤(KRAS)]的突变状态对于靶向治疗具有重要价值,因为它是一种非侵入性且成本较低的方法。尽管深度学习技术已在计算机视觉领域取得了显著成就,但由于数据集规模较小,利用CT成像预测基因突变仍然具有挑战性。

方法

我们提出了一种多通道多任务深度学习(MMDL)模型,用于基于CT图像同时预测EGFR和KRAS的突变状态。首先,我们将每个3D肺结节分解为9个视图。然后,我们对每个视图使用预训练的inception-attention-resnet模型来学习结节的特征。通过组合9个inception-attention-resnet模型来预测肺结节中的基因突变类型,对模型进行自适应加权,并对提出的MMDL模型进行端到端训练。MMDL模型利用多个通道更全面地表征结节,并将患者个人信息整合到我们的学习过程中。

结果

我们使用合作医院收集的363例患者的数据集对提出的MMDL模型进行了训练,并在癌症影像存档(TCIA)公共数据集中对162例患者进行了多中心验证。在训练数据集中,EGFR和KRAS突变预测的准确率分别为79.43%和72.25%,在验证数据集中分别为75.06%和69.64%。

结论

实验结果表明,所提出的MMDL模型在预测NSCLC中EGFR和KRAS突变方面优于最新方法。